Pharmaceutical Breakthroughs
Pharmaceutical Breakthroughs (PB) is a leading peer-reviewed journal dedicated to the publication of high-impact research in drug development, clinical pharmacology, and pharmaceutical sciences.
Journal Details
Acceptance Rate
14%
Review Type
Double-Blind
Published
Bimonthly
Access
Open Access
Scope
Pharmaceutical Breakthroughs (PB) is a leading peer-reviewed journal dedicated to the publication of high-impact research in drug development, clinical pharmacology, and pharmaceutical sciences. It serves as an authoritative resource for researchers, clinicians, and industry professionals.
Aims & Objectives
PB aims to accelerate the translation of pharmaceutical research from bench to bedside by publishing landmark discoveries in drug design, formulation science, clinical trials, and regulatory pathways. We prioritize research that has direct implications for patient outcomes and public health.
Subject Areas
Article Types Accepted
Peer Review Process
Step 01
Initial Screening
Editorial team reviews scope fit and formatting within 5 business days.
Step 02
Double-Blind Review
Minimum two independent expert reviewers assess originality, methodology, and contribution.
Step 03
Decision & DOI
Authors receive a decision. Accepted articles receive a CrossRef DOI and are published open access.
Submit to this Journal
Ready to submit your research?
We accept original research, review articles, and case studies on a rolling basis. All accepted work receives a DOI and is published open access.
Submit a PaperEditor-in-Chief
Prof. David Chen
Johns Hopkins School of Medicine
Indexed & Abstracted In
Publication Info
Editorial Enquiries
For editorial enquiries related to this journal, contact our publishing team.
Contact Editorial Office →Open for Submissions
Publish your research in PB.
We accept original research, systematic reviews, meta-analyses, and more. All submissions undergo double-blind peer review and receive a CrossRef DOI upon acceptance.
Explore More
Browse all 10 Guinness Press journals